Carcinoma, Transitional Cell - 25 Studies Found

Completed : Safety and Efficacy of JS001 for Patients With Locally Advanced or Metastatic Bladder Urothelial Carcinoma
: Bladder Urothelial Carcinoma
: 2017-04-06
: Biological: humanized anti-PD-1 monoclonal antibody humanized anti-PD-1 monoclonal antibody (JS001) is a
Recruiting : DNA Methylation and Arsenic-associated Urothelial Carcinoma
: Urothelial Carcinoma
: 2011-05-24
Completed : Study of MPDL3280A in Bladder Cancer
: Carcinoma, Transitional Cell
: 2015-03-04
:
  • Drug: MPDL3280A Dose Level 1 1
Completed : The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
: Carcinoma, Transitional Cell
: 2016-05-29
: Drug: MitoGel™ instillations Treatment with MitoGel™ once weekly for a total of 6 times; in
Completed : Tesetaxel for Previously Treated Patients With Bladder Cancer
: Carcinoma, Transitional Cell
: 2010-10-05
: Drug: Tesetaxel Tesetaxel capsules orally once every 21 da
<<< Previous